New Woodlands storefront brings hologram technology to the car-shopping experience

vr-oom

The Woodlands Mall shoppers can schedule virtual test drives, complete purchases, schedule deliveries of vehicles and meet with staff at this new high-tech store. Photo courtesy of JLL

The Woodlands-based online pre-owned car purveyor evrdrive has opened its flagship Customer Experience Center, or CXC, at The Woodlands Mall.

Designed by JLL Design Solutions, the modern space will allow shoppers to virtually tour the company's fleet of vehicles through its evrViewTM 3D hologram technology. According to a release, the technology can show evrdrive's full inventory of SUVs, cars, trucks, or other body styles and can display the vehicle's model specifications and history.

From the storefront, shoppers can also schedule virtual test drives, complete purchases, schedule deliveries of vehicles and meet with staff.

"We believe evrdrive is the future of automotive retail, and we are committed to providing our customers with a seamless and enjoyable shopping experience," Brian Singh, CEO of evrdrive, said in a statement.

evrdrive was founded in 2022, according to LinkedIn, and is part of Foundation Automotive Corp, a Houston-based company that owns car dealerships in the U.S. and Canada.

The company also runs a 55,000-square-foot Reconditioning Hub in the Houston area where vehicles are inspected and refurbished.

A number of new innovative auto ventures have rolled into Houston in recent months.

Self-driving ridehailing service Cruise expanded into Houston with its all electric, driverless cars in early May. The company launched services in Austin at the start of the year.

Uber Technologies, Inc. and Nuro also partnered last September to provide autonomous, electric vehicles for food deliveries in Houston. That same month, Drvn, a global on-demand chauffeur service, began operating in the Bayou City.

Drvn offers tech-savvy service, high-end cars, and various ride options. Photo courtesy of drvn

New tech-enabled chauffeur service stretches into Houston with upscale ride options

stay classy

Discriminating Houstonians who opt for luxury/executive car services (and who don’t, unfortunately, have a limo and driver of their own) now can choose an innovative, tech-savvy option.

Drvn, a global chauffeur service, has just rolled into Houston. Customers can look forward to on-demand rides — 24 hours a day — in various, upscale vehicles. Options start with first class; cars offered include sedans (Mercedes S Class, BMW 7 Series, or similar); SUVs (Cadillac Escalade, Lincoln Navigator, or similar); and even vans (such as the Mercedes 1500).

Business class also offers sedans (Cadillac XTS, Lincoln Continental, or similar); SUVs (Chevrolet Suburban, Ford Expedition, or similar); and also vans (Ford Transit or similar).

Private charters for posh parties or travel parties include Grech minibuses (or similar) that can seat up to 36 passengers. Limousines are available upon request and subject to availability. All vehicles are black, for a more classic touch.

Just in time for society/gala season, drvn offers locals rides to events all around Greater Houston, as well as both major airports. (Drvn’s CEO David Medina tells CultureMap that the service is a hit in its Coral Gables, Florida headquarters, where well-heeled customers use it for event travel.)

Other service areas include port transfers to and from the Port of Galveston; drvn’s long-distance car service to Dallas; Oklahoma City; Shreveport, Louisiana; Baton Rouge, Louisiana; Little Rock, Arkansas; and beyond. Drvn staff expects major demand for events, conventions, and conferences, plus executive car service for business clients.

Currently, those interested can book rides via the drvn site. Medina notes that a customer app is scheduled for later this year.

As for the cost: A simple search from the Memorial Park area to Bush Intercontinental Airport yielded point-to-point rides starting at around $226 in an executive class sedan. Users can also schedule and even request special cars and opt for hourly service (perfect for weddings, occasions, and that visiting celebrity friend).

Aiming to separate itself from local high-end car services, drvn promises “five-star, white-glove transportation” options, cutting-edge booking technology, and drivers who meticulously train and even undergo secret rides from drvn staff to assure quality control. Drvn hopes to entice business/executive car service clients with tech such as God’s view and GPS tracking (to keep tabs on the boss’s car), a live manifest, and uniform billing and communication.

Medina also hopes to separate his company by redefining what luxury actually means when it comes to car service.

“‘Luxury’ does not mean luxury for high-end private car service,” he says. “Luxury is a Flying Spur or a Bentayga, not a Mercedes S Class or an Escalade. But, a Bentley is not what is in the mind of professionals who seek ‘luxury’ private car service. It is a state of being. It is knowing, without saying, that your chauffeur not only has your best interests in mind, he has your experience in mind. It is part of his duty of care to know what you expect and deliver it with elegance and with no visible exertion. It is through the simplicity of this balance that drvn’s chauffeured service delivers a ‘luxury’ experience. Not the Bentley.”

------

This article originally ran on CultureMap.

NuVinAir ReKlenz-X is safe for use in vehicles and can be used without damaging the interior. Photo courtesy of NuVinAir

New product sold in Houston gets EPA approval as eco-friendly, coronavirus-killing car cleaner

IN-CAR TECH

With the onset of COVID-19, the public is more aware than ever of cross-contamination, which extends from your home to your business to your car, and beyond.

NuVinAir announced that its latest product, ReKlenz-X, has gotten approval from the Environmental Protection Agency (EPA) as an eco-friendly disinfectant. The company's Houston affiliate, Brian Ross, is selling the product.

ReKlenz-X kills 99.9 percent of germs, bacteria, and viruses in a vehicle's interior without compromising the integrity of the cabin. The product is on the EPA's "List N", which includes disinfectants for use to combat SARS-CoV-2, the virus that causes COVID-19."NuVinAir has proudly been at the forefront of helping ensure healthier commutes to drivers and passengers since launching in 2015. Adding this EPA-approved, oxygen-infused product that actually kills what's behind the coronavirus gives us an exciting extension to our 'Total Health' application," says Kyle Bailey, NuVinAir Global's CEO and founder.

"Our science-backed ReKlenz-X disinfectant cleans, protects, and disinfects safely and effectively — it's everything our automotive partners need in guaranteeing their customers' confidence in a safer, healthier vehicle," he continues.

To clean, the proprietary product uses an oxygen-enriched formula to quickly kills bacteria and viruses by destroying their cell walls through a process called oxidation. According to NuVinAir, ReKlenz-X contains no harsh chemicals, sticky residue, or dangerous volatile organic compounds. The result is a disinfected vehicle with no chemical smell.

ReKlenz-X is available in 32-ounce spray bottles through automotive dealerships, detail shops, rental-car companies, service centers, and vehicle fleets.

"Until now, any possible solution for killing the coronavirus was wrought with harmful chemicals, expensive equipment, and residue-leaving application devices that destroy the vehicle's interior," said Troy Blackwell, Chief Operating Officer for NuVinAir Global. "As a disinfectant and sanitizer, it can be applied to all interior vehicle surfaces using a microfiber towel. Paired with our premier detailing solution, ReNuSurface, as well as our patented Cyclone treatment, it takes deep cleaning to a whole new level for our automotive partners and their customers."

Dallas, Texas-based NuVinAir sells their products through a franchise system, similar to Line-X's business model.

------

This article originally ran on AutomotiveMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

Alzheimer’s research

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March.

Dr. Ryan S. Dhindsa is an assistant professor of pathology & immunology at Baylor and a principal investigator at Texas Children’s Duncan Neurological Research Institute (Duncan NRI). He hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation.

“It is an honor to receive this support from the Cure One, Cure Many Award. Viral infections are emerging as a major, underappreciated driver of Alzheimer's disease, and this award will allow our team to conduct the most comprehensive screen of viral exposures and host genetics in Alzheimer's to date, spanning over a million individuals,” Dhindsa said in a news release. “Our goal is to identify which viruses matter most, why some people are more vulnerable than others, and ultimately move the field closer to new therapeutic strategies for patients.”

Roughly 150 million people worldwide will suffer from Alzheimer’s by 2050, making it the most common cause of dementia in the world. Despite this, scientists are still at a loss as to what exactly causes it.

Dhindsa’s research is part of a new range of theories that certain viral infections may trigger Alzheimer’s. His team will take a two-fold approach. First, they will analyze the medical records of more than a million individuals looking for patterns. Second, they will analyze viral DNA in stem cell-derived brain cells to see how the infections could contribute to neurological decay. The scale of the genomic data gathering is unprecedented and may highlight a link that traditional studies have missed.

Also joining the project are Dr. Caleb Lareau of Memorial Sloan Kettering Cancer Center and Dr. Artem Babaian of the University of Toronto. Should a link be found, it would open the door to using anti-virals to prevent or treat Alzheimer’s.

View All Listings